Walleye Capital LLC Zai Lab LTD Call Options Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$16.25 - $24.14 $130,000 - $193,120	-8,000 Reduced 28.07%	20,500 $494,000
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $352,604 - $553,835	25,700 Added 917.86%	28,500 $493,000
Q1 2024 May 15, 2024	SELL	$15.95 - $26.8 $11,165 - $18,760	-700 Reduced 20.0%	2,800 $44,000
Q4 2023 Feb 14, 2024	BUY	$22.97 - $30.58 $80,395 - $107,030	3,500 New	3,500 $95,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.63B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.